BeOne Medicines (ONC) Total Debt Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 5.94% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 103.99% |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | - |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 0.07% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | - |
| 10 | BeOne Medicines | - | - | 1.35 Bn | 16.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.78% |
| Dec 31, 2025 | 0.12% |
| Sep 30, 2025 | 56.57% |
| Jun 30, 2025 | -7.95% |
| Mar 31, 2025 | -9.98% |
| Dec 31, 2024 | 14.90% |
| Sep 30, 2024 | 97.97% |
| Jun 30, 2024 | 64.99% |
| Mar 31, 2024 | 110.20% |
| Dec 31, 2023 | 323.62% |
| Sep 30, 2023 | -18.22% |
| Jun 30, 2023 | 11.05% |
| Mar 31, 2023 | -19.85% |
| Dec 31, 2022 | -66.78% |
| Sep 30, 2022 | 0.94% |
| Jun 30, 2022 | -10.12% |
| Mar 31, 2022 | 1.83% |
| Dec 31, 2021 | 21.41% |
| Sep 30, 2021 | 3,999.14% |
| Jun 30, 2021 | 238.12% |
| Mar 31, 2021 | 541.62% |
| Dec 31, 2020 | 522.55% |
| Sep 30, 2020 | -89.64% |
| Jun 30, 2020 | 99.75% |
| Mar 31, 2020 | -43.20% |
| Dec 31, 2019 | -47.14% |
| Sep 30, 2019 | 205.61% |
| Jun 30, 2019 | -41.10% |
| Mar 31, 2019 | 0.00% |
| Dec 31, 2018 | 1.36% |
| Sep 30, 2018 | 174.78% |
| Jun 30, 2018 | 794.21% |
| Mar 31, 2018 | 724.54% |
| Dec 31, 2017 | 799.64% |
| Sep 30, 2017 | 0.03% |
| Jun 30, 2017 | 67.73% |
| Mar 31, 2017 | 220.31% |
| Dec 31, 2016 | -16.85% |